Rilonacept Pharmacokinetics in Children With Systemic Juvenile Idiopathic Arthritis

被引:14
作者
Autmizguine, Julie [1 ]
Cohen-Wolkowiez, Michael [1 ]
Ilowite, Norman [2 ]
机构
[1] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA
[2] Childrens Hosp Montefiore, Albert Einstein Coll Med, Bronx, NY USA
基金
美国国家卫生研究院;
关键词
systemic juvenile idiopathic arthritis; interleukin-1; inhibitor; population pharmacokinetics; pediatrics; SAFETY; PHARMACODYNAMICS; EPIDEMIOLOGY; PATHOGENESIS; EFFICACY;
D O I
10.1002/jcph.372
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:39 / 44
页数:6
相关论文
共 20 条
[1]   Understanding dosing: children are small adults, neonates are immature children [J].
Anderson, Brian J. ;
Holford, Nick H. G. .
ARCHIVES OF DISEASE IN CHILDHOOD, 2013, 98 (09) :737-744
[2]   THEORETICAL MODEL OF GAMMA-GLOBULIN CATABOLISM [J].
BRAMBELL, FW ;
HEMMINGS, WA ;
MORRIS, IG .
NATURE, 1964, 203 (495) :1352-&
[3]   Health outcomes in pediatric rheumatic diseases [J].
Duffy, CM .
CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (02) :102-108
[4]  
GARE BA, 1992, PEDIATRICS, V90, P950
[5]  
Giannini EH, 1997, ARTHRITIS RHEUM, V40, P1202
[6]   Efficacy and safety of rilonacept (Interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes [J].
Hoffman, Hal M. ;
Throne, Martin L. ;
Amar, N. J. ;
Sebai, Mohamed ;
Kivitz, Alan J. ;
Kavanaugh, Arthur ;
Weinstein, Steven P. ;
Belomestnov, Pavel ;
Yancopoulos, George D. ;
Stahl, Neil ;
Mellis, Scott J. .
ARTHRITIS AND RHEUMATISM, 2008, 58 (08) :2443-2452
[7]   A size standard for pharmacokinetics [J].
Holford, NHG .
CLINICAL PHARMACOKINETICS, 1996, 30 (05) :329-332
[8]  
Ilowite N.T., 2014, Arthritis rheumatology
[9]   Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis [J].
Lovell, Daniel J. ;
Giannini, Edward H. ;
Reiff, Andreas O. ;
Kimura, Yukiko ;
Li, Suzanne ;
Hashkes, Philip J. ;
Wallace, Carol A. ;
Onel, Karen B. ;
Foell, Dirk ;
Wu, Richard ;
Biedermann, Stephanie ;
Hamilton, Jennifer D. ;
Radin, Allen R. .
ARTHRITIS AND RHEUMATISM, 2013, 65 (09) :2486-2496
[10]   Pharmacokinetics and pharmacodynamics of multiple weekly subcutaneous efalizumab doses in patients with plaque psoriasis [J].
Mortensen, DL ;
Walicke, PA ;
Wang, XL ;
Kwon, P ;
Kuebler, P ;
Gottlieb, AB ;
Krueger, JG ;
Leonardi, C ;
Miller, B ;
Joshi, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (03) :286-298